Back to Journals » Infection and Drug Resistance » Volume 9

Infection and Drug Resistance

ISSN: 1178-6973


Archive: Volume 9, 2016

Availability, perceptions, and characteristics of antibiograms among Illinois pediatricians

Spiekerman KM, Patel SJ, Patel R, Kociolek LK

Infection and Drug Resistance 2016, 9:269-274

Published Date: 5 December 2016

Assessing parasite clearance during uncomplicated Plasmodium falciparum infection treated with artesunate monotherapy in Suriname

Vreden SGS, Bansie RD, Jitan JK, Adhin MR

Infection and Drug Resistance 2016, 9:261-267

Published Date: 24 November 2016

The pharmacokinetics of vancomycin during the initial loading dose in patients with septic shock

Katip W, Jaruratanasirikul S, Pattharachayakul S, Wongpoowarak W, Jitsurong A, Lucksiri A

Infection and Drug Resistance 2016, 9:253-260

Published Date: 22 November 2016

Evaluating vancomycin susceptibility in Staphylococcus aureus

Mimica MJ, Navarini A

Infection and Drug Resistance 2016, 9:239-241

Published Date: 26 September 2016

Aspergillus fumigatus in the cystic fibrosis lung: pros and cons of azole therapy

Burgel PR, Paugam A, Hubert D, Martin C

Infection and Drug Resistance 2016, 9:229-238

Published Date: 20 September 2016

Lemierre’s syndrome: current perspectives on diagnosis and management

Johannesen KM, Bodtger U

Infection and Drug Resistance 2016, 9:221-227

Published Date: 14 September 2016

Lyme disease: the promise of Big Data, companion diagnostics and precision medicine

Stricker RB, Johnson L

Infection and Drug Resistance 2016, 9:215-219

Published Date: 13 September 2016

Pelvic inflammatory disease: improving awareness, prevention, and treatment

Das BB, Ronda J, Trent M

Infection and Drug Resistance 2016, 9:191-197

Published Date: 19 August 2016

Emerging resistant serotypes of invasive Streptococcus pneumoniae

Elshafie S, Taj-Aldeen SJ

Infection and Drug Resistance 2016, 9:153-160

Published Date: 29 June 2016

Concern over Zika virus outbreak: another alarming global threat

Hafiz MY, Mahmood SU, Shoaib M, Yusuf FH

Infection and Drug Resistance 2016, 9:149-151

Published Date: 28 June 2016

Optimal management of genital herpes: current perspectives

Sauerbrei A

Infection and Drug Resistance 2016, 9:129-141

Published Date: 13 June 2016

Conceptual framework for outcomes research studies of hepatitis C: an analytical review

Sbarigia U, Denee TR, Turner NG, Wan GJ, Morrison A, Kaufman AS, Rice G, Dusheiko GM

Infection and Drug Resistance 2016, 9:101-117

Published Date: 27 May 2016

Isavuconazole in the treatment of invasive aspergillosis and mucormycosis infections

Donnelley MA, Zhu ES, Thompson GR 3rd

Infection and Drug Resistance 2016, 9:79-86

Published Date: 2 June 2016

Enzymatic degradation of in vitro Staphylococcus aureus biofilms supplemented with human plasma

Watters CM, Burton T, Kirui DK, Millenbaugh NJ

Infection and Drug Resistance 2016, 9:71-78

Published Date: 27 April 2016

Species-based comparison of disease severity and risk factors for disseminated Candida infections in pediatric patients

Hawkshead III JJ, Van Dyke RB, Hassig SE, Webber LS, Begue RE

Infection and Drug Resistance 2016, 9:59-70

Published Date: 18 April 2016

Daptomycin: an evidence-based review of its role in the treatment of Gram-positive infections

Gonzalez-Ruiz A, Seaton RA, Hamed K

Infection and Drug Resistance 2016, 9:47-58

Published Date: 15 April 2016

Methicillin-resistant Staphylococcus aureus multiple sites surveillance: a systemic review of the literature

Chipolombwe J, Török ME, Mbelle N, Nyasulu P

Infection and Drug Resistance 2016, 9:35-42

Published Date: 12 February 2016

Pseudomonas aeruginosa ventilator-associated pneumonia management

Ramírez-Estrada S, Borgatta B, Rello J

Infection and Drug Resistance 2016, 9:7-18

Published Date: 20 January 2016